US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 47.240
  • +1.220+2.65%
Close Nov 22 16:00 ET
  • 47.240
  • 0.0000.00%
Post 20:01 ET
4.36BMarket Cap-7439P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.16%-67M
33.74%-76.96M
-21.59%-190.73M
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
-12.33%-380.47M
-66.24%-90.34M
Net income from continuing operations
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
Depreciation and amortization
21.78%8.76M
65.30%8.86M
68.93%8.85M
42.73%26.01M
65.79%8.22M
53.20%7.19M
19.64%5.36M
28.08%5.24M
37.62%18.22M
40.27%4.96M
Other non cash items
-492.03%-10.84M
-40,640.74%-11M
-120.96%-2.29M
-101.10%-1.06M
-214.99%-10.14M
-102.17%-1.83M
-102.76%-27K
514.32%10.94M
721.17%96.13M
877.18%8.82M
Change In working capital
1,001.00%30.83M
128.50%16.36M
-46.02%-56.02M
-125.07%-15.1M
-39.11%13.3M
-87.37%2.8M
-74.35%7.16M
-228.21%-38.36M
195.25%60.24M
5.60%21.85M
-Change in receivables
257.83%9.79M
114.31%2.16M
-893.14%-24.91M
-88.75%-22.78M
111.13%1.01M
-204.64%-6.2M
-68.75%-15.08M
-7,700.00%-2.51M
-122.16%-12.07M
-196.25%-9.1M
-Change in inventory
27.89%-2.5M
-149.06%-4.13M
-1,516.00%-2.12M
28.56%-6.93M
53.48%-1.96M
-338.31%-3.47M
48.70%-1.66M
110.17%150K
-211.23%-9.7M
-324.75%-4.21M
-Change in prepaid assets
----
----
1,362.62%6.55M
303.50%15.33M
-138.86%-1.26M
----
----
-105.69%-519K
112.87%3.8M
114.38%3.24M
-Change in payables and accrued expense
44.61%10.82M
115.00%25.33M
-0.15%-35.54M
-97.28%2.38M
-46.88%18.61M
-32.94%7.48M
-79.48%11.78M
-119.54%-35.49M
170.61%87.44M
15.24%35.03M
-Change in other working capital
----
----
----
66.46%-3.1M
----
----
----
----
83.94%-9.24M
-118.47%-3.12M
Cash from discontinued investing activities
Operating cash flow
43.16%-67M
33.74%-76.96M
-21.59%-190.73M
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
-12.33%-380.47M
-66.24%-90.34M
Investing cash flow
Cash flow from continuing investing activities
-528.50%-275.5M
-39.08%60.56M
-15.16%94.44M
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
-49.28%-291.65M
-348.49%-171.6M
Net PPE purchase and sale
56.24%-1.62M
85.59%-2.01M
87.17%-3.21M
61.88%-44.27M
94.07%-1.6M
85.81%-3.7M
54.93%-13.94M
22.22%-25.03M
-58.87%-116.12M
-68.06%-26.97M
Net intangibles purchase and sale
--0
0.00%-2.5M
---10M
91.67%-2.5M
--0
--0
---2.5M
--0
---30M
--0
Net business purchase and sale
----
----
----
--0
----
----
----
----
---75.03M
--366K
Net investment purchase and sale
-500.01%-273.68M
-43.99%65.11M
-21.80%109.71M
415.55%219.82M
27.18%-105.15M
213.57%68.42M
5.42%116.25M
467.93%140.29M
42.59%-69.66M
-268.76%-144.39M
Net other investing changes
52.57%-203K
89.70%-41K
47.73%-2.07M
-498.10%-5.05M
55.13%-271K
-141.81%-428K
-117.49%-398K
-3,392.50%-3.95M
10.40%-844K
-32.75%-604K
Cash from discontinued investing activities
Investing cash flow
-528.50%-275.5M
-39.08%60.56M
-15.16%94.44M
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
-49.28%-291.65M
-348.49%-171.6M
Financing cash flow
Cash flow from continuing financing activities
-55.72%11.17M
1,065.78%384.94M
91.97%-58K
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
322.77%501.21M
-97.80%1.88M
Net common stock issuance
-99.53%117K
----
----
--379.76M
--326.46M
--24.79M
----
----
--0
--0
Proceeds from stock option exercised by employees
817.87%4.06M
-10.86%4.07M
92.27%-58K
-22.18%8.42M
107.60%4.15M
-58.85%442K
-23.63%4.57M
-142.74%-750K
-73.04%10.81M
-71.10%2M
Net other financing activities
----
----
----
-100.01%-28K
--0
--0
61.64%-56K
119.58%28K
99,773.78%490.4M
16.20%-119K
Cash from discontinued financing activities
Financing cash flow
-55.72%11.17M
1,065.78%384.94M
91.97%-58K
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
322.77%501.21M
-97.80%1.88M
Net cash flow
Beginning cash position
355.35%490.26M
33.70%122.37M
59.45%219.4M
-55.55%137.6M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
-55.55%137.6M
-57.37%309.59M
89.13%396.31M
Current changes in cash
-1,068.89%-331.32M
2,164.18%368.54M
-108.17%-96.35M
147.59%81.34M
153.71%139.69M
-112.08%-28.35M
110.08%16.28M
69.80%-46.29M
58.87%-170.91M
-358.92%-260.06M
Effect of exchange rate changes
278.07%1.28M
-376.47%-648K
-421.80%-679K
142.98%462K
-18.42%1.1M
33.77%-716K
89.01%-136K
295.37%211K
9.97%-1.08M
444.90%1.35M
End cash Position
103.82%160.21M
355.35%490.26M
33.70%122.37M
59.45%219.4M
59.45%219.4M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
-55.55%137.6M
-55.55%137.6M
Free cash flow
43.56%-68.61M
38.56%-81.47M
-12.11%-203.94M
0.95%-521.57M
27.11%-85.5M
-0.15%-121.57M
-22.57%-132.6M
-1.22%-181.9M
-27.88%-526.59M
-66.66%-117.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.16%-67M33.74%-76.96M-21.59%-190.73M-24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M-12.33%-380.47M-66.24%-90.34M
Net income from continuing operations 16.37%-133.52M17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M
Depreciation and amortization 21.78%8.76M65.30%8.86M68.93%8.85M42.73%26.01M65.79%8.22M53.20%7.19M19.64%5.36M28.08%5.24M37.62%18.22M40.27%4.96M
Other non cash items -492.03%-10.84M-40,640.74%-11M-120.96%-2.29M-101.10%-1.06M-214.99%-10.14M-102.17%-1.83M-102.76%-27K514.32%10.94M721.17%96.13M877.18%8.82M
Change In working capital 1,001.00%30.83M128.50%16.36M-46.02%-56.02M-125.07%-15.1M-39.11%13.3M-87.37%2.8M-74.35%7.16M-228.21%-38.36M195.25%60.24M5.60%21.85M
-Change in receivables 257.83%9.79M114.31%2.16M-893.14%-24.91M-88.75%-22.78M111.13%1.01M-204.64%-6.2M-68.75%-15.08M-7,700.00%-2.51M-122.16%-12.07M-196.25%-9.1M
-Change in inventory 27.89%-2.5M-149.06%-4.13M-1,516.00%-2.12M28.56%-6.93M53.48%-1.96M-338.31%-3.47M48.70%-1.66M110.17%150K-211.23%-9.7M-324.75%-4.21M
-Change in prepaid assets --------1,362.62%6.55M303.50%15.33M-138.86%-1.26M---------105.69%-519K112.87%3.8M114.38%3.24M
-Change in payables and accrued expense 44.61%10.82M115.00%25.33M-0.15%-35.54M-97.28%2.38M-46.88%18.61M-32.94%7.48M-79.48%11.78M-119.54%-35.49M170.61%87.44M15.24%35.03M
-Change in other working capital ------------66.46%-3.1M----------------83.94%-9.24M-118.47%-3.12M
Cash from discontinued investing activities
Operating cash flow 43.16%-67M33.74%-76.96M-21.59%-190.73M-24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M-12.33%-380.47M-66.24%-90.34M
Investing cash flow
Cash flow from continuing investing activities -528.50%-275.5M-39.08%60.56M-15.16%94.44M157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M-49.28%-291.65M-348.49%-171.6M
Net PPE purchase and sale 56.24%-1.62M85.59%-2.01M87.17%-3.21M61.88%-44.27M94.07%-1.6M85.81%-3.7M54.93%-13.94M22.22%-25.03M-58.87%-116.12M-68.06%-26.97M
Net intangibles purchase and sale --00.00%-2.5M---10M91.67%-2.5M--0--0---2.5M--0---30M--0
Net business purchase and sale --------------0-------------------75.03M--366K
Net investment purchase and sale -500.01%-273.68M-43.99%65.11M-21.80%109.71M415.55%219.82M27.18%-105.15M213.57%68.42M5.42%116.25M467.93%140.29M42.59%-69.66M-268.76%-144.39M
Net other investing changes 52.57%-203K89.70%-41K47.73%-2.07M-498.10%-5.05M55.13%-271K-141.81%-428K-117.49%-398K-3,392.50%-3.95M10.40%-844K-32.75%-604K
Cash from discontinued investing activities
Investing cash flow -528.50%-275.5M-39.08%60.56M-15.16%94.44M157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M-49.28%-291.65M-348.49%-171.6M
Financing cash flow
Cash flow from continuing financing activities -55.72%11.17M1,065.78%384.94M91.97%-58K-22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K322.77%501.21M-97.80%1.88M
Net common stock issuance -99.53%117K----------379.76M--326.46M--24.79M----------0--0
Proceeds from stock option exercised by employees 817.87%4.06M-10.86%4.07M92.27%-58K-22.18%8.42M107.60%4.15M-58.85%442K-23.63%4.57M-142.74%-750K-73.04%10.81M-71.10%2M
Net other financing activities -------------100.01%-28K--0--061.64%-56K119.58%28K99,773.78%490.4M16.20%-119K
Cash from discontinued financing activities
Financing cash flow -55.72%11.17M1,065.78%384.94M91.97%-58K-22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K322.77%501.21M-97.80%1.88M
Net cash flow
Beginning cash position 355.35%490.26M33.70%122.37M59.45%219.4M-55.55%137.6M-80.17%78.61M-33.83%107.67M-41.41%91.53M-55.55%137.6M-57.37%309.59M89.13%396.31M
Current changes in cash -1,068.89%-331.32M2,164.18%368.54M-108.17%-96.35M147.59%81.34M153.71%139.69M-112.08%-28.35M110.08%16.28M69.80%-46.29M58.87%-170.91M-358.92%-260.06M
Effect of exchange rate changes 278.07%1.28M-376.47%-648K-421.80%-679K142.98%462K-18.42%1.1M33.77%-716K89.01%-136K295.37%211K9.97%-1.08M444.90%1.35M
End cash Position 103.82%160.21M355.35%490.26M33.70%122.37M59.45%219.4M59.45%219.4M-80.17%78.61M-33.83%107.67M-41.41%91.53M-55.55%137.6M-55.55%137.6M
Free cash flow 43.56%-68.61M38.56%-81.47M-12.11%-203.94M0.95%-521.57M27.11%-85.5M-0.15%-121.57M-22.57%-132.6M-1.22%-181.9M-27.88%-526.59M-66.66%-117.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data